Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DiaceuticsDIUXF 85 3-Year Book Growth Rate is -1.80% as of Dec. 2025. GuruFocus rates DIUXF with a GF Score™ of 85/100 and a GF Value™ of $2.71. The stock has 1 warning sign investors should review. Among 580 Healthcare Providers & Services companies, Diaceutics ranks worse than 71.55% on this metric.
During the past 12 months, Diaceutics's average Book Value per Share Growth Rate was 1.30% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -1.80% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -0.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Diaceutics was 168.10% per year. The lowest was -1.80% per year. And the median was 20.40% per year.
Diaceutics (OTCPK:DIUXF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Diaceutics 3-Year Book Growth Rate Related Terms
DIUXF vs VEEV, BTSG, HQY: 3-Year Book Growth Rate Comparison
For the Health Information Services subindustry, Diaceutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diaceutics 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diaceutics's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Diaceutics's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of -1.80% mean?
Diaceutics (DIUXF) has a 3-Year Book Growth Rate of -1.80% as of Dec. 2025. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Diaceutics and its competitors. According to the industry distribution chart, Diaceutics ranks #415 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 71.6%.
Is Diaceutics' 3-Year Book Growth Rate too high?
Diaceutics' current 3-Year Book Growth Rate is -1.80%. Based on the distribution chart, Diaceutics ranks #415 out of 580 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Diaceutics has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' 3-Year Book Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diaceutics ranks #415 out of 580 companies for 3-Year Book Growth Rate. This places Diaceutics in the lower half of its industry. The industry median 3-Year Book Growth Rate is 5.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.50, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Diaceutics and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diaceutics's current 3-Year Book Growth Rate is -1.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Diaceutics (DIUXF) has a current 3-Year Book Growth Rate of -1.80%. The stock's GF Value™ is $2.71, compared to a current price of $2.00 — trading 26.2% below its estimated fair value. The current 3-Year Book Growth Rate is -1.80%. Diaceutics' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Diaceutics (DIUXF), the current 3-Year Book Growth Rate is -1.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diaceutics (DIUXF) Overvalued in 2026?
Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued.
The current stock price of $2.00 is trading 26.2% below its estimated GF Value™ of $2.71.
Key valuation signals for DIUXF:
3-Year Book Growth Rate: -1.80%
GF Value™: $2.71 vs. price of $2.00 (26.2% below fair value)
No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
85GF Score
Get the complete analysis for DIUXF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DIUXF has been successfully added to your 
